Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer

Clinical trial NCT07184021 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07184021
Sponsor: Assiut University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Cancer

Start date: 2025-09-01
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.